AF Therapy Development Manager NYC Brooklyn, NY, USA Hoboken, NJ, USA Manhattan, New York, NY, USA New York, NY, USA Virtual Req #2066 Friday, April 26, 2024 Who We Are AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around

AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions in cardiac tissue for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage. Cardiothoracic surgeons are adopting AtriCure’s ablation products

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy Ablation System is the